nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—CYP2C9—Sorafenib—liver cancer	0.0632	0.294	CbGbCtD
Donepezil—CYP2D6—Sorafenib—liver cancer	0.0578	0.269	CbGbCtD
Donepezil—CYP3A4—Sorafenib—liver cancer	0.0368	0.171	CbGbCtD
Donepezil—CYP2D6—Doxorubicin—liver cancer	0.0351	0.163	CbGbCtD
Donepezil—CYP3A4—Doxorubicin—liver cancer	0.0223	0.104	CbGbCtD
Donepezil—Hot flush—Doxorubicin—liver cancer	0.00104	0.00161	CcSEcCtD
Donepezil—Increased appetite—Doxorubicin—liver cancer	0.00104	0.0016	CcSEcCtD
Donepezil—Affect lability—Epirubicin—liver cancer	0.00104	0.0016	CcSEcCtD
Donepezil—Menopausal symptoms—Doxorubicin—liver cancer	0.00103	0.0016	CcSEcCtD
Donepezil—Hypersensitivity—Sorafenib—liver cancer	0.00103	0.0016	CcSEcCtD
Donepezil—Dermatitis bullous—Doxorubicin—liver cancer	0.00102	0.00158	CcSEcCtD
Donepezil—Face oedema—Epirubicin—liver cancer	0.00102	0.00157	CcSEcCtD
Donepezil—Asthenia—Sorafenib—liver cancer	0.00101	0.00155	CcSEcCtD
Donepezil—Hypoglycaemia—Doxorubicin—liver cancer	0.000999	0.00154	CcSEcCtD
Donepezil—Cardiac failure—Doxorubicin—liver cancer	0.000999	0.00154	CcSEcCtD
Donepezil—Mood swings—Epirubicin—liver cancer	0.000998	0.00154	CcSEcCtD
Donepezil—Cerebrovascular accident—Doxorubicin—liver cancer	0.000995	0.00154	CcSEcCtD
Donepezil—Pruritus—Sorafenib—liver cancer	0.000991	0.00153	CcSEcCtD
Donepezil—Ataxia—Epirubicin—liver cancer	0.000991	0.00153	CcSEcCtD
Donepezil—Blood creatinine increased—Epirubicin—liver cancer	0.000987	0.00153	CcSEcCtD
Donepezil—Dehydration—Epirubicin—liver cancer	0.00098	0.00152	CcSEcCtD
Donepezil—Hyponatraemia—Doxorubicin—liver cancer	0.000979	0.00151	CcSEcCtD
Donepezil—Osteoarthritis—Doxorubicin—liver cancer	0.000975	0.00151	CcSEcCtD
Donepezil—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000975	0.00151	CcSEcCtD
Donepezil—Liver function test abnormal—Epirubicin—liver cancer	0.000973	0.0015	CcSEcCtD
Donepezil—Dry skin—Epirubicin—liver cancer	0.000966	0.00149	CcSEcCtD
Donepezil—Orthostatic hypotension—Epirubicin—liver cancer	0.000962	0.00149	CcSEcCtD
Donepezil—Abdominal pain upper—Epirubicin—liver cancer	0.000962	0.00149	CcSEcCtD
Donepezil—Affect lability—Doxorubicin—liver cancer	0.000959	0.00148	CcSEcCtD
Donepezil—Hypokalaemia—Epirubicin—liver cancer	0.000959	0.00148	CcSEcCtD
Donepezil—Diarrhoea—Sorafenib—liver cancer	0.000959	0.00148	CcSEcCtD
Donepezil—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000949	0.00147	CcSEcCtD
Donepezil—Nasopharyngitis—Epirubicin—liver cancer	0.000942	0.00146	CcSEcCtD
Donepezil—Face oedema—Doxorubicin—liver cancer	0.000941	0.00146	CcSEcCtD
Donepezil—Gastritis—Epirubicin—liver cancer	0.000932	0.00144	CcSEcCtD
Donepezil—Muscular weakness—Epirubicin—liver cancer	0.000929	0.00144	CcSEcCtD
Donepezil—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000929	0.00144	CcSEcCtD
Donepezil—Dizziness—Sorafenib—liver cancer	0.000926	0.00143	CcSEcCtD
Donepezil—Mood swings—Doxorubicin—liver cancer	0.000923	0.00143	CcSEcCtD
Donepezil—Abdominal distension—Epirubicin—liver cancer	0.000917	0.00142	CcSEcCtD
Donepezil—Ataxia—Doxorubicin—liver cancer	0.000916	0.00142	CcSEcCtD
Donepezil—Blood creatinine increased—Doxorubicin—liver cancer	0.000913	0.00141	CcSEcCtD
Donepezil—Dysphagia—Epirubicin—liver cancer	0.00091	0.00141	CcSEcCtD
Donepezil—Asthma—Epirubicin—liver cancer	0.00091	0.00141	CcSEcCtD
Donepezil—Influenza—Epirubicin—liver cancer	0.00091	0.00141	CcSEcCtD
Donepezil—Dehydration—Doxorubicin—liver cancer	0.000906	0.0014	CcSEcCtD
Donepezil—Eosinophilia—Epirubicin—liver cancer	0.000901	0.00139	CcSEcCtD
Donepezil—Liver function test abnormal—Doxorubicin—liver cancer	0.0009	0.00139	CcSEcCtD
Donepezil—Dry skin—Doxorubicin—liver cancer	0.000893	0.00138	CcSEcCtD
Donepezil—Pancreatitis—Epirubicin—liver cancer	0.000893	0.00138	CcSEcCtD
Donepezil—Vomiting—Sorafenib—liver cancer	0.000891	0.00138	CcSEcCtD
Donepezil—Abdominal pain upper—Doxorubicin—liver cancer	0.00089	0.00138	CcSEcCtD
Donepezil—Orthostatic hypotension—Doxorubicin—liver cancer	0.00089	0.00138	CcSEcCtD
Donepezil—Hypokalaemia—Doxorubicin—liver cancer	0.000887	0.00137	CcSEcCtD
Donepezil—Angina pectoris—Epirubicin—liver cancer	0.000887	0.00137	CcSEcCtD
Donepezil—Rash—Sorafenib—liver cancer	0.000883	0.00137	CcSEcCtD
Donepezil—Dermatitis—Sorafenib—liver cancer	0.000882	0.00137	CcSEcCtD
Donepezil—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000878	0.00136	CcSEcCtD
Donepezil—Headache—Sorafenib—liver cancer	0.000878	0.00136	CcSEcCtD
Donepezil—Bronchitis—Epirubicin—liver cancer	0.000876	0.00135	CcSEcCtD
Donepezil—Nasopharyngitis—Doxorubicin—liver cancer	0.000872	0.00135	CcSEcCtD
Donepezil—Gastritis—Doxorubicin—liver cancer	0.000863	0.00133	CcSEcCtD
Donepezil—Muscular weakness—Doxorubicin—liver cancer	0.00086	0.00133	CcSEcCtD
Donepezil—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00086	0.00133	CcSEcCtD
Donepezil—Dysuria—Epirubicin—liver cancer	0.000851	0.00132	CcSEcCtD
Donepezil—Abdominal distension—Doxorubicin—liver cancer	0.000848	0.00131	CcSEcCtD
Donepezil—Influenza—Doxorubicin—liver cancer	0.000842	0.0013	CcSEcCtD
Donepezil—Asthma—Doxorubicin—liver cancer	0.000842	0.0013	CcSEcCtD
Donepezil—Dysphagia—Doxorubicin—liver cancer	0.000842	0.0013	CcSEcCtD
Donepezil—Pollakiuria—Epirubicin—liver cancer	0.000841	0.0013	CcSEcCtD
Donepezil—Eosinophilia—Doxorubicin—liver cancer	0.000834	0.00129	CcSEcCtD
Donepezil—Nausea—Sorafenib—liver cancer	0.000832	0.00129	CcSEcCtD
Donepezil—Weight increased—Epirubicin—liver cancer	0.000829	0.00128	CcSEcCtD
Donepezil—Pancreatitis—Doxorubicin—liver cancer	0.000826	0.00128	CcSEcCtD
Donepezil—Weight decreased—Epirubicin—liver cancer	0.000824	0.00127	CcSEcCtD
Donepezil—Hyperglycaemia—Epirubicin—liver cancer	0.000821	0.00127	CcSEcCtD
Donepezil—Angina pectoris—Doxorubicin—liver cancer	0.000821	0.00127	CcSEcCtD
Donepezil—Pneumonia—Epirubicin—liver cancer	0.000816	0.00126	CcSEcCtD
Donepezil—Infestation NOS—Epirubicin—liver cancer	0.000812	0.00126	CcSEcCtD
Donepezil—Infestation—Epirubicin—liver cancer	0.000812	0.00126	CcSEcCtD
Donepezil—Bronchitis—Doxorubicin—liver cancer	0.00081	0.00125	CcSEcCtD
Donepezil—Renal failure—Epirubicin—liver cancer	0.000798	0.00123	CcSEcCtD
Donepezil—Jaundice—Epirubicin—liver cancer	0.000791	0.00122	CcSEcCtD
Donepezil—Urinary tract infection—Epirubicin—liver cancer	0.000789	0.00122	CcSEcCtD
Donepezil—Conjunctivitis—Epirubicin—liver cancer	0.000789	0.00122	CcSEcCtD
Donepezil—Dysuria—Doxorubicin—liver cancer	0.000788	0.00122	CcSEcCtD
Donepezil—Sweating—Epirubicin—liver cancer	0.000778	0.0012	CcSEcCtD
Donepezil—Pollakiuria—Doxorubicin—liver cancer	0.000778	0.0012	CcSEcCtD
Donepezil—Haematuria—Epirubicin—liver cancer	0.000774	0.0012	CcSEcCtD
Donepezil—Weight increased—Doxorubicin—liver cancer	0.000767	0.00119	CcSEcCtD
Donepezil—Epistaxis—Epirubicin—liver cancer	0.000766	0.00118	CcSEcCtD
Donepezil—Weight decreased—Doxorubicin—liver cancer	0.000762	0.00118	CcSEcCtD
Donepezil—Hyperglycaemia—Doxorubicin—liver cancer	0.00076	0.00118	CcSEcCtD
Donepezil—Pneumonia—Doxorubicin—liver cancer	0.000755	0.00117	CcSEcCtD
Donepezil—Infestation NOS—Doxorubicin—liver cancer	0.000751	0.00116	CcSEcCtD
Donepezil—Infestation—Doxorubicin—liver cancer	0.000751	0.00116	CcSEcCtD
Donepezil—Bradycardia—Epirubicin—liver cancer	0.000742	0.00115	CcSEcCtD
Donepezil—Renal failure—Doxorubicin—liver cancer	0.000738	0.00114	CcSEcCtD
Donepezil—Haemoglobin—Epirubicin—liver cancer	0.000732	0.00113	CcSEcCtD
Donepezil—Jaundice—Doxorubicin—liver cancer	0.000732	0.00113	CcSEcCtD
Donepezil—Rhinitis—Epirubicin—liver cancer	0.000731	0.00113	CcSEcCtD
Donepezil—Urinary tract infection—Doxorubicin—liver cancer	0.00073	0.00113	CcSEcCtD
Donepezil—Conjunctivitis—Doxorubicin—liver cancer	0.00073	0.00113	CcSEcCtD
Donepezil—Haemorrhage—Epirubicin—liver cancer	0.000729	0.00113	CcSEcCtD
Donepezil—Hepatitis—Epirubicin—liver cancer	0.000729	0.00113	CcSEcCtD
Donepezil—Hypoaesthesia—Epirubicin—liver cancer	0.000725	0.00112	CcSEcCtD
Donepezil—Pharyngitis—Epirubicin—liver cancer	0.000723	0.00112	CcSEcCtD
Donepezil—Sweating—Doxorubicin—liver cancer	0.00072	0.00111	CcSEcCtD
Donepezil—Urinary tract disorder—Epirubicin—liver cancer	0.00072	0.00111	CcSEcCtD
Donepezil—Oedema peripheral—Epirubicin—liver cancer	0.000718	0.00111	CcSEcCtD
Donepezil—Haematuria—Doxorubicin—liver cancer	0.000716	0.00111	CcSEcCtD
Donepezil—Urethral disorder—Epirubicin—liver cancer	0.000714	0.0011	CcSEcCtD
Donepezil—Epistaxis—Doxorubicin—liver cancer	0.000708	0.0011	CcSEcCtD
Donepezil—Visual impairment—Epirubicin—liver cancer	0.000702	0.00109	CcSEcCtD
Donepezil—Bradycardia—Doxorubicin—liver cancer	0.000686	0.00106	CcSEcCtD
Donepezil—Tinnitus—Epirubicin—liver cancer	0.000679	0.00105	CcSEcCtD
Donepezil—Haemoglobin—Doxorubicin—liver cancer	0.000678	0.00105	CcSEcCtD
Donepezil—Rhinitis—Doxorubicin—liver cancer	0.000676	0.00105	CcSEcCtD
Donepezil—Haemorrhage—Doxorubicin—liver cancer	0.000674	0.00104	CcSEcCtD
Donepezil—Hepatitis—Doxorubicin—liver cancer	0.000674	0.00104	CcSEcCtD
Donepezil—Hypoaesthesia—Doxorubicin—liver cancer	0.000671	0.00104	CcSEcCtD
Donepezil—Pharyngitis—Doxorubicin—liver cancer	0.000669	0.00104	CcSEcCtD
Donepezil—Urinary tract disorder—Doxorubicin—liver cancer	0.000666	0.00103	CcSEcCtD
Donepezil—Oedema peripheral—Doxorubicin—liver cancer	0.000664	0.00103	CcSEcCtD
Donepezil—Urethral disorder—Doxorubicin—liver cancer	0.000661	0.00102	CcSEcCtD
Donepezil—Chills—Epirubicin—liver cancer	0.000654	0.00101	CcSEcCtD
Donepezil—Arrhythmia—Epirubicin—liver cancer	0.000651	0.00101	CcSEcCtD
Donepezil—Visual impairment—Doxorubicin—liver cancer	0.00065	0.00101	CcSEcCtD
Donepezil—Alopecia—Epirubicin—liver cancer	0.000644	0.000996	CcSEcCtD
Donepezil—Mental disorder—Epirubicin—liver cancer	0.000638	0.000988	CcSEcCtD
Donepezil—Malnutrition—Epirubicin—liver cancer	0.000634	0.000981	CcSEcCtD
Donepezil—Erythema—Epirubicin—liver cancer	0.000634	0.000981	CcSEcCtD
Donepezil—Tinnitus—Doxorubicin—liver cancer	0.000629	0.000972	CcSEcCtD
Donepezil—Flatulence—Epirubicin—liver cancer	0.000625	0.000967	CcSEcCtD
Donepezil—Tension—Epirubicin—liver cancer	0.000623	0.000963	CcSEcCtD
Donepezil—Dysgeusia—Epirubicin—liver cancer	0.000621	0.000961	CcSEcCtD
Donepezil—Nervousness—Epirubicin—liver cancer	0.000616	0.000953	CcSEcCtD
Donepezil—Back pain—Epirubicin—liver cancer	0.000614	0.000949	CcSEcCtD
Donepezil—Muscle spasms—Epirubicin—liver cancer	0.00061	0.000943	CcSEcCtD
Donepezil—Chills—Doxorubicin—liver cancer	0.000605	0.000936	CcSEcCtD
Donepezil—Arrhythmia—Doxorubicin—liver cancer	0.000602	0.000932	CcSEcCtD
Donepezil—Vision blurred—Epirubicin—liver cancer	0.000598	0.000925	CcSEcCtD
Donepezil—Alopecia—Doxorubicin—liver cancer	0.000596	0.000922	CcSEcCtD
Donepezil—Mental disorder—Doxorubicin—liver cancer	0.000591	0.000914	CcSEcCtD
Donepezil—Ill-defined disorder—Epirubicin—liver cancer	0.000589	0.00091	CcSEcCtD
Donepezil—Malnutrition—Doxorubicin—liver cancer	0.000587	0.000908	CcSEcCtD
Donepezil—Erythema—Doxorubicin—liver cancer	0.000587	0.000908	CcSEcCtD
Donepezil—Anaemia—Epirubicin—liver cancer	0.000586	0.000907	CcSEcCtD
Donepezil—Agitation—Epirubicin—liver cancer	0.000583	0.000902	CcSEcCtD
Donepezil—Flatulence—Doxorubicin—liver cancer	0.000578	0.000895	CcSEcCtD
Donepezil—Tension—Doxorubicin—liver cancer	0.000576	0.000891	CcSEcCtD
Donepezil—Dysgeusia—Doxorubicin—liver cancer	0.000575	0.000889	CcSEcCtD
Donepezil—Malaise—Epirubicin—liver cancer	0.000572	0.000885	CcSEcCtD
Donepezil—Nervousness—Doxorubicin—liver cancer	0.00057	0.000882	CcSEcCtD
Donepezil—Vertigo—Epirubicin—liver cancer	0.00057	0.000882	CcSEcCtD
Donepezil—Syncope—Epirubicin—liver cancer	0.000569	0.00088	CcSEcCtD
Donepezil—Back pain—Doxorubicin—liver cancer	0.000568	0.000878	CcSEcCtD
Donepezil—Muscle spasms—Doxorubicin—liver cancer	0.000564	0.000873	CcSEcCtD
Donepezil—Loss of consciousness—Epirubicin—liver cancer	0.000558	0.000862	CcSEcCtD
Donepezil—Cough—Epirubicin—liver cancer	0.000554	0.000856	CcSEcCtD
Donepezil—Vision blurred—Doxorubicin—liver cancer	0.000553	0.000856	CcSEcCtD
Donepezil—Convulsion—Epirubicin—liver cancer	0.00055	0.00085	CcSEcCtD
Donepezil—Hypertension—Epirubicin—liver cancer	0.000548	0.000847	CcSEcCtD
Donepezil—Ill-defined disorder—Doxorubicin—liver cancer	0.000545	0.000842	CcSEcCtD
Donepezil—Anaemia—Doxorubicin—liver cancer	0.000543	0.000839	CcSEcCtD
Donepezil—Arthralgia—Epirubicin—liver cancer	0.00054	0.000835	CcSEcCtD
Donepezil—Chest pain—Epirubicin—liver cancer	0.00054	0.000835	CcSEcCtD
Donepezil—Myalgia—Epirubicin—liver cancer	0.00054	0.000835	CcSEcCtD
Donepezil—Agitation—Doxorubicin—liver cancer	0.000539	0.000834	CcSEcCtD
Donepezil—Anxiety—Epirubicin—liver cancer	0.000538	0.000833	CcSEcCtD
Donepezil—Discomfort—Epirubicin—liver cancer	0.000534	0.000825	CcSEcCtD
Donepezil—Malaise—Doxorubicin—liver cancer	0.000529	0.000819	CcSEcCtD
Donepezil—Dry mouth—Epirubicin—liver cancer	0.000528	0.000817	CcSEcCtD
Donepezil—Vertigo—Doxorubicin—liver cancer	0.000527	0.000816	CcSEcCtD
Donepezil—Syncope—Doxorubicin—liver cancer	0.000526	0.000814	CcSEcCtD
Donepezil—Confusional state—Epirubicin—liver cancer	0.000522	0.000808	CcSEcCtD
Donepezil—Oedema—Epirubicin—liver cancer	0.000518	0.000801	CcSEcCtD
Donepezil—Loss of consciousness—Doxorubicin—liver cancer	0.000516	0.000798	CcSEcCtD
Donepezil—Infection—Epirubicin—liver cancer	0.000514	0.000796	CcSEcCtD
Donepezil—Cough—Doxorubicin—liver cancer	0.000512	0.000792	CcSEcCtD
Donepezil—Shock—Epirubicin—liver cancer	0.000509	0.000788	CcSEcCtD
Donepezil—Convulsion—Doxorubicin—liver cancer	0.000509	0.000787	CcSEcCtD
Donepezil—Nervous system disorder—Epirubicin—liver cancer	0.000508	0.000785	CcSEcCtD
Donepezil—Thrombocytopenia—Epirubicin—liver cancer	0.000507	0.000784	CcSEcCtD
Donepezil—Hypertension—Doxorubicin—liver cancer	0.000507	0.000784	CcSEcCtD
Donepezil—Hyperhidrosis—Epirubicin—liver cancer	0.000501	0.000774	CcSEcCtD
Donepezil—Myalgia—Doxorubicin—liver cancer	0.0005	0.000773	CcSEcCtD
Donepezil—Chest pain—Doxorubicin—liver cancer	0.0005	0.000773	CcSEcCtD
Donepezil—Arthralgia—Doxorubicin—liver cancer	0.0005	0.000773	CcSEcCtD
Donepezil—Anxiety—Doxorubicin—liver cancer	0.000498	0.00077	CcSEcCtD
Donepezil—Discomfort—Doxorubicin—liver cancer	0.000494	0.000764	CcSEcCtD
Donepezil—Anorexia—Epirubicin—liver cancer	0.000494	0.000763	CcSEcCtD
Donepezil—Dry mouth—Doxorubicin—liver cancer	0.000489	0.000756	CcSEcCtD
Donepezil—Hypotension—Epirubicin—liver cancer	0.000484	0.000748	CcSEcCtD
Donepezil—Confusional state—Doxorubicin—liver cancer	0.000483	0.000747	CcSEcCtD
Donepezil—Oedema—Doxorubicin—liver cancer	0.000479	0.000741	CcSEcCtD
Donepezil—Infection—Doxorubicin—liver cancer	0.000476	0.000736	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000472	0.00073	CcSEcCtD
Donepezil—Shock—Doxorubicin—liver cancer	0.000471	0.000729	CcSEcCtD
Donepezil—Nervous system disorder—Doxorubicin—liver cancer	0.00047	0.000727	CcSEcCtD
Donepezil—Thrombocytopenia—Doxorubicin—liver cancer	0.000469	0.000726	CcSEcCtD
Donepezil—Insomnia—Epirubicin—liver cancer	0.000468	0.000724	CcSEcCtD
Donepezil—Paraesthesia—Epirubicin—liver cancer	0.000465	0.000719	CcSEcCtD
Donepezil—Hyperhidrosis—Doxorubicin—liver cancer	0.000463	0.000716	CcSEcCtD
Donepezil—Dyspnoea—Epirubicin—liver cancer	0.000462	0.000714	CcSEcCtD
Donepezil—Somnolence—Epirubicin—liver cancer	0.00046	0.000712	CcSEcCtD
Donepezil—Anorexia—Doxorubicin—liver cancer	0.000457	0.000706	CcSEcCtD
Donepezil—Dyspepsia—Epirubicin—liver cancer	0.000456	0.000705	CcSEcCtD
Donepezil—Decreased appetite—Epirubicin—liver cancer	0.00045	0.000696	CcSEcCtD
Donepezil—Hypotension—Doxorubicin—liver cancer	0.000448	0.000692	CcSEcCtD
Donepezil—Gastrointestinal disorder—Epirubicin—liver cancer	0.000447	0.000691	CcSEcCtD
Donepezil—Fatigue—Epirubicin—liver cancer	0.000446	0.00069	CcSEcCtD
Donepezil—Pain—Epirubicin—liver cancer	0.000443	0.000685	CcSEcCtD
Donepezil—Constipation—Epirubicin—liver cancer	0.000443	0.000685	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000436	0.000675	CcSEcCtD
Donepezil—Insomnia—Doxorubicin—liver cancer	0.000433	0.00067	CcSEcCtD
Donepezil—Paraesthesia—Doxorubicin—liver cancer	0.00043	0.000665	CcSEcCtD
Donepezil—Dyspnoea—Doxorubicin—liver cancer	0.000427	0.000661	CcSEcCtD
Donepezil—Feeling abnormal—Epirubicin—liver cancer	0.000427	0.00066	CcSEcCtD
Donepezil—Somnolence—Doxorubicin—liver cancer	0.000426	0.000659	CcSEcCtD
Donepezil—Gastrointestinal pain—Epirubicin—liver cancer	0.000423	0.000655	CcSEcCtD
Donepezil—Dyspepsia—Doxorubicin—liver cancer	0.000422	0.000652	CcSEcCtD
Donepezil—Decreased appetite—Doxorubicin—liver cancer	0.000416	0.000644	CcSEcCtD
Donepezil—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000414	0.00064	CcSEcCtD
Donepezil—Fatigue—Doxorubicin—liver cancer	0.000413	0.000639	CcSEcCtD
Donepezil—Urticaria—Epirubicin—liver cancer	0.000411	0.000636	CcSEcCtD
Donepezil—Pain—Doxorubicin—liver cancer	0.00041	0.000634	CcSEcCtD
Donepezil—Constipation—Doxorubicin—liver cancer	0.00041	0.000634	CcSEcCtD
Donepezil—Body temperature increased—Epirubicin—liver cancer	0.000409	0.000633	CcSEcCtD
Donepezil—Abdominal pain—Epirubicin—liver cancer	0.000409	0.000633	CcSEcCtD
Donepezil—Feeling abnormal—Doxorubicin—liver cancer	0.000395	0.000611	CcSEcCtD
Donepezil—Gastrointestinal pain—Doxorubicin—liver cancer	0.000392	0.000606	CcSEcCtD
Donepezil—Hypersensitivity—Epirubicin—liver cancer	0.000381	0.00059	CcSEcCtD
Donepezil—Urticaria—Doxorubicin—liver cancer	0.000381	0.000589	CcSEcCtD
Donepezil—Body temperature increased—Doxorubicin—liver cancer	0.000379	0.000586	CcSEcCtD
Donepezil—Abdominal pain—Doxorubicin—liver cancer	0.000379	0.000586	CcSEcCtD
Donepezil—Asthenia—Epirubicin—liver cancer	0.000371	0.000575	CcSEcCtD
Donepezil—Pruritus—Epirubicin—liver cancer	0.000366	0.000567	CcSEcCtD
Donepezil—Diarrhoea—Epirubicin—liver cancer	0.000354	0.000548	CcSEcCtD
Donepezil—Hypersensitivity—Doxorubicin—liver cancer	0.000353	0.000546	CcSEcCtD
Donepezil—Asthenia—Doxorubicin—liver cancer	0.000344	0.000532	CcSEcCtD
Donepezil—Dizziness—Epirubicin—liver cancer	0.000342	0.00053	CcSEcCtD
Donepezil—Pruritus—Doxorubicin—liver cancer	0.000339	0.000524	CcSEcCtD
Donepezil—Vomiting—Epirubicin—liver cancer	0.000329	0.000509	CcSEcCtD
Donepezil—Diarrhoea—Doxorubicin—liver cancer	0.000328	0.000507	CcSEcCtD
Donepezil—Rash—Epirubicin—liver cancer	0.000326	0.000505	CcSEcCtD
Donepezil—Dermatitis—Epirubicin—liver cancer	0.000326	0.000504	CcSEcCtD
Donepezil—Headache—Epirubicin—liver cancer	0.000324	0.000502	CcSEcCtD
Donepezil—Dizziness—Doxorubicin—liver cancer	0.000317	0.00049	CcSEcCtD
Donepezil—Nausea—Epirubicin—liver cancer	0.000308	0.000476	CcSEcCtD
Donepezil—Vomiting—Doxorubicin—liver cancer	0.000305	0.000471	CcSEcCtD
Donepezil—Rash—Doxorubicin—liver cancer	0.000302	0.000467	CcSEcCtD
Donepezil—Dermatitis—Doxorubicin—liver cancer	0.000302	0.000467	CcSEcCtD
Donepezil—Headache—Doxorubicin—liver cancer	0.0003	0.000464	CcSEcCtD
Donepezil—Nausea—Doxorubicin—liver cancer	0.000285	0.00044	CcSEcCtD
Donepezil—HRH3—Signaling by GPCR—IL2—liver cancer	9.44e-05	0.000682	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TERT—liver cancer	9.4e-05	0.00068	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	9.3e-05	0.000672	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—TAT—liver cancer	9.25e-05	0.000669	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—F2—liver cancer	9.19e-05	0.000664	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—TAT—liver cancer	9.17e-05	0.000663	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—CYP1A1—liver cancer	9.07e-05	0.000656	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—F2—liver cancer	9.04e-05	0.000654	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	9.02e-05	0.000652	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	8.95e-05	0.000647	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.95e-05	0.000647	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.83e-05	0.000639	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PSMD10—liver cancer	8.81e-05	0.000637	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PSMA4—liver cancer	8.81e-05	0.000637	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—KDR—liver cancer	8.6e-05	0.000622	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GOT2—liver cancer	8.57e-05	0.000619	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MAPK14—liver cancer	8.54e-05	0.000618	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ESR1—liver cancer	8.38e-05	0.000606	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—F2—liver cancer	8.28e-05	0.000598	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—IL6—liver cancer	8.2e-05	0.000593	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CYP2E1—liver cancer	8.05e-05	0.000582	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—PIK3CA—liver cancer	8.01e-05	0.000579	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—APC—liver cancer	7.92e-05	0.000573	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CG—liver cancer	7.92e-05	0.000573	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—liver cancer	7.8e-05	0.000564	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.8e-05	0.000564	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—MMP2—liver cancer	7.79e-05	0.000563	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—HRAS—liver cancer	7.78e-05	0.000562	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CYCS—liver cancer	7.54e-05	0.000545	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FST—liver cancer	7.5e-05	0.000542	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—BRAF—liver cancer	7.45e-05	0.000538	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GGT1—liver cancer	7.4e-05	0.000535	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GOT1—liver cancer	7.4e-05	0.000535	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PRKCE—liver cancer	7.36e-05	0.000532	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—liver cancer	7.17e-05	0.000518	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TRIO—liver cancer	7.15e-05	0.000517	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CD—liver cancer	6.96e-05	0.000503	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—PIK3CA—liver cancer	6.9e-05	0.000499	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—SERPINE1—liver cancer	6.89e-05	0.000498	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCR4—liver cancer	6.86e-05	0.000496	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—KRAS—liver cancer	6.82e-05	0.000493	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—UGDH—liver cancer	6.79e-05	0.000491	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	6.75e-05	0.000488	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PRKCE—liver cancer	6.68e-05	0.000483	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTP1—liver cancer	6.64e-05	0.00048	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	6.63e-05	0.000479	CbGpPWpGaD
Donepezil—ACHE—Metabolism—HMOX1—liver cancer	6.55e-05	0.000474	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CSF2—liver cancer	6.51e-05	0.000471	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—EPT1—liver cancer	6.38e-05	0.000461	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	6.35e-05	0.000459	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CPT1B—liver cancer	6.29e-05	0.000455	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GLUL—liver cancer	6.29e-05	0.000455	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—PIK3CA—liver cancer	6.26e-05	0.000453	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GLUL—liver cancer	6.23e-05	0.000451	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CPT1B—liver cancer	6.23e-05	0.000451	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—RAF1—liver cancer	6.22e-05	0.000449	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTM1—liver cancer	6.1e-05	0.000441	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CB—liver cancer	6.07e-05	0.000439	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MTOR—liver cancer	6.07e-05	0.000439	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NR1H4—liver cancer	6.06e-05	0.000439	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TAT—liver cancer	6.05e-05	0.000437	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NR1H4—liver cancer	6.01e-05	0.000435	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—CTNNB1—liver cancer	5.97e-05	0.000432	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTA3—liver cancer	5.96e-05	0.000431	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CSF2—liver cancer	5.91e-05	0.000427	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTA3—liver cancer	5.91e-05	0.000427	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—HRAS—liver cancer	5.79e-05	0.000419	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CYP1A1—liver cancer	5.79e-05	0.000418	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CDKN1B—liver cancer	5.7e-05	0.000412	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—AKT1—liver cancer	5.63e-05	0.000407	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CASP3—liver cancer	5.58e-05	0.000404	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL2—liver cancer	5.57e-05	0.000403	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—IL6—liver cancer	5.55e-05	0.000401	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTA4—liver cancer	5.45e-05	0.000394	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CCND1—liver cancer	5.43e-05	0.000393	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—JUN—liver cancer	5.42e-05	0.000392	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ADAM17—liver cancer	5.42e-05	0.000392	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTA4—liver cancer	5.41e-05	0.000391	CbGpPWpGaD
Donepezil—ACHE—Metabolism—MTHFR—liver cancer	5.39e-05	0.00039	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CTNNB1—liver cancer	5.38e-05	0.000389	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTA2—liver cancer	5.31e-05	0.000384	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PPARA—liver cancer	5.29e-05	0.000383	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	5.28e-05	0.000382	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MMP9—liver cancer	5.28e-05	0.000381	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTA2—liver cancer	5.27e-05	0.000381	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CDKN1A—liver cancer	5.26e-05	0.00038	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MAPK8—liver cancer	5.13e-05	0.000371	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTA1—liver cancer	5.13e-05	0.000371	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—AKT1—liver cancer	5.12e-05	0.00037	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—F2—liver cancer	5.11e-05	0.000369	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PSMA4—liver cancer	5.1e-05	0.000368	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PSMD10—liver cancer	5.1e-05	0.000368	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTA1—liver cancer	5.08e-05	0.000368	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NAT2—liver cancer	5.07e-05	0.000367	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NAT2—liver cancer	5.03e-05	0.000363	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CG—liver cancer	4.89e-05	0.000353	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALDOB—liver cancer	4.86e-05	0.000351	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.83e-05	0.000349	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALDOB—liver cancer	4.82e-05	0.000348	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.75e-05	0.000344	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—VEGFA—liver cancer	4.74e-05	0.000343	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—STAT3—liver cancer	4.69e-05	0.000339	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—F2—liver cancer	4.64e-05	0.000335	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CRABP1—liver cancer	4.64e-05	0.000335	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CRABP1—liver cancer	4.6e-05	0.000332	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CG—liver cancer	4.53e-05	0.000328	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CG—liver cancer	4.44e-05	0.000321	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PPARG—liver cancer	4.37e-05	0.000316	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MYC—liver cancer	4.36e-05	0.000315	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TGFB1—liver cancer	4.35e-05	0.000314	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CD—liver cancer	4.3e-05	0.000311	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.14e-05	0.000299	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CPT1B—liver cancer	4.11e-05	0.000297	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GLUL—liver cancer	4.11e-05	0.000297	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HPGDS—liver cancer	4.05e-05	0.000293	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—KRAS—liver cancer	4.03e-05	0.000291	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HPGDS—liver cancer	4.02e-05	0.000291	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.99e-05	0.000289	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CD—liver cancer	3.98e-05	0.000288	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NR1H4—liver cancer	3.97e-05	0.000287	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PRKCE—liver cancer	3.95e-05	0.000285	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ALB—liver cancer	3.93e-05	0.000284	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CD—liver cancer	3.9e-05	0.000282	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTA3—liver cancer	3.9e-05	0.000282	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CB—liver cancer	3.75e-05	0.000271	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IGF2—liver cancer	3.74e-05	0.00027	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CA—liver cancer	3.7e-05	0.000268	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.64e-05	0.000263	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PSMA4—liver cancer	3.61e-05	0.000261	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PSMD10—liver cancer	3.61e-05	0.000261	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.59e-05	0.00026	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PSMA4—liver cancer	3.58e-05	0.000259	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PSMD10—liver cancer	3.58e-05	0.000259	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TP53—liver cancer	3.58e-05	0.000259	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTA4—liver cancer	3.57e-05	0.000258	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GOT2—liver cancer	3.51e-05	0.000254	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CSF2—liver cancer	3.49e-05	0.000252	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—RAF1—liver cancer	3.48e-05	0.000252	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GOT2—liver cancer	3.48e-05	0.000252	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTA2—liver cancer	3.47e-05	0.000251	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CB—liver cancer	3.47e-05	0.000251	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—H2AFX—liver cancer	3.44e-05	0.000249	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—IL2—liver cancer	3.44e-05	0.000249	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HRAS—liver cancer	3.42e-05	0.000248	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CB—liver cancer	3.4e-05	0.000246	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTA1—liver cancer	3.35e-05	0.000242	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NAT2—liver cancer	3.31e-05	0.00024	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP2E1—liver cancer	3.3e-05	0.000239	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL6—liver cancer	3.28e-05	0.000237	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP2E1—liver cancer	3.28e-05	0.000237	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALDOB—liver cancer	3.18e-05	0.00023	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.17e-05	0.000229	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL2—liver cancer	3.12e-05	0.000226	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TERT—liver cancer	3.11e-05	0.000225	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYCS—liver cancer	3.09e-05	0.000224	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYCS—liver cancer	3.06e-05	0.000222	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GOT1—liver cancer	3.03e-05	0.000219	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GGT1—liver cancer	3.03e-05	0.000219	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CRABP1—liver cancer	3.03e-05	0.000219	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—AKT1—liver cancer	3.02e-05	0.000219	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GGT1—liver cancer	3.01e-05	0.000217	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GOT1—liver cancer	3.01e-05	0.000217	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KDR—liver cancer	2.85e-05	0.000206	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAPK14—liver cancer	2.83e-05	0.000204	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ESR1—liver cancer	2.77e-05	0.000201	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—F2—liver cancer	2.74e-05	0.000198	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTP1—liver cancer	2.72e-05	0.000197	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTP1—liver cancer	2.7e-05	0.000195	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HMOX1—liver cancer	2.69e-05	0.000194	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HMOX1—liver cancer	2.66e-05	0.000193	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HPGDS—liver cancer	2.65e-05	0.000192	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CG—liver cancer	2.62e-05	0.00019	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APC—liver cancer	2.62e-05	0.00019	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTM1—liver cancer	2.5e-05	0.000181	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTM1—liver cancer	2.48e-05	0.000179	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—BRAF—liver cancer	2.46e-05	0.000178	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP1A1—liver cancer	2.37e-05	0.000172	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PSMA4—liver cancer	2.36e-05	0.000171	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PSMD10—liver cancer	2.36e-05	0.000171	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP1A1—liver cancer	2.35e-05	0.00017	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CD—liver cancer	2.31e-05	0.000167	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GOT2—liver cancer	2.3e-05	0.000166	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CA—liver cancer	2.28e-05	0.000165	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SERPINE1—liver cancer	2.28e-05	0.000165	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—KRAS—liver cancer	2.26e-05	0.000163	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—MTHFR—liver cancer	2.21e-05	0.00016	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—MTHFR—liver cancer	2.19e-05	0.000159	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPARA—liver cancer	2.17e-05	0.000157	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP2E1—liver cancer	2.16e-05	0.000156	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPARA—liver cancer	2.15e-05	0.000156	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CA—liver cancer	2.12e-05	0.000153	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CA—liver cancer	2.07e-05	0.00015	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RAF1—liver cancer	2.06e-05	0.000149	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYCS—liver cancer	2.02e-05	0.000146	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MTOR—liver cancer	2.01e-05	0.000145	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CB—liver cancer	2.01e-05	0.000145	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GOT1—liver cancer	1.98e-05	0.000143	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GGT1—liver cancer	1.98e-05	0.000143	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.93e-05	0.00014	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—HRAS—liver cancer	1.92e-05	0.000139	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CDKN1B—liver cancer	1.89e-05	0.000136	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AKT1—liver cancer	1.87e-05	0.000135	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CG—liver cancer	1.86e-05	0.000134	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CASP3—liver cancer	1.85e-05	0.000134	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL2—liver cancer	1.85e-05	0.000133	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CG—liver cancer	1.84e-05	0.000133	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL6—liver cancer	1.84e-05	0.000133	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCND1—liver cancer	1.8e-05	0.00013	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—JUN—liver cancer	1.8e-05	0.00013	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPARG—liver cancer	1.79e-05	0.00013	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CTNNB1—liver cancer	1.78e-05	0.000129	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTP1—liver cancer	1.78e-05	0.000129	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPARG—liver cancer	1.78e-05	0.000129	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HMOX1—liver cancer	1.76e-05	0.000127	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP9—liver cancer	1.75e-05	0.000126	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CDKN1A—liver cancer	1.74e-05	0.000126	CbGpPWpGaD
Donepezil—ACHE—Metabolism—AKT1—liver cancer	1.73e-05	0.000125	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAPK8—liver cancer	1.7e-05	0.000123	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AKT1—liver cancer	1.69e-05	0.000122	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTM1—liver cancer	1.64e-05	0.000118	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CD—liver cancer	1.63e-05	0.000118	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CD—liver cancer	1.62e-05	0.000117	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALB—liver cancer	1.61e-05	0.000117	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALB—liver cancer	1.6e-05	0.000116	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—VEGFA—liver cancer	1.57e-05	0.000113	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—STAT3—liver cancer	1.55e-05	0.000112	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP1A1—liver cancer	1.55e-05	0.000112	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MTHFR—liver cancer	1.45e-05	0.000105	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MYC—liver cancer	1.44e-05	0.000104	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TGFB1—liver cancer	1.44e-05	0.000104	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CB—liver cancer	1.42e-05	0.000103	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPARA—liver cancer	1.42e-05	0.000103	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CB—liver cancer	1.41e-05	0.000102	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KRAS—liver cancer	1.33e-05	9.64e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CA—liver cancer	1.22e-05	8.86e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CG—liver cancer	1.22e-05	8.79e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TP53—liver cancer	1.18e-05	8.57e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPARG—liver cancer	1.17e-05	8.48e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HRAS—liver cancer	1.13e-05	8.19e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL6—liver cancer	1.08e-05	7.84e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CD—liver cancer	1.07e-05	7.73e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALB—liver cancer	1.05e-05	7.63e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AKT1—liver cancer	1e-05	7.24e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CB—liver cancer	9.31e-06	6.73e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CA—liver cancer	8.68e-06	6.28e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CA—liver cancer	8.61e-06	6.23e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—AKT1—liver cancer	7.09e-06	5.13e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—AKT1—liver cancer	7.03e-06	5.09e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CA—liver cancer	5.68e-06	4.11e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AKT1—liver cancer	4.64e-06	3.35e-05	CbGpPWpGaD
